May 12, 2020 May 12, 2020Key Biologics and Astarte Biologics Rebrand as Cellero and Announce Completion of Phase One of $50 Million Multi-Year Expansion Plan
March 4, 2020 March 4, 2020Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts
February 26, 2020 February 26, 2020Adaptas Solutions to Acquire Applied Kilovolts and Analytical Instrumentation Business from L3Harris Technologies
January 28, 2020 January 28, 2020Arranta Bio announces key leadership additions of Chief Operations Officer and SVP of Business Development as it commits to a $100M investment in building end-to-end microbiome capacity
January 17, 2020 January 17, 2020Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services
January 13, 2020 January 13, 2020Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners
